Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial

Circulation

Volumn 97, Issue 6, 1998, Pages 562-568

  Van de Watering, Leo M G ^a,b   Hermans, Jo ^d   Houbiers, Jos G A ^a   Van den Broek, Pieter J ^d   Bouter, Hens ^d   Boer, Fred ^d   Harvey, Mark S ^a   Huysmans, Hans A ^d   Brand, Anneke ^a,b,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c Blood Bank Leidsenhage   (Netherlands)

^d NONE

Author keywords

Blood; Coronary disease; Leukocytes; Mortality; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART SURGERY; HEMOFILTRATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY;

EID: 0031937028     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.6.562     Document Type: Article

References (38)

1. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood. 1994;84:1703-1721.
2. Brand A, White cell depletion: Why and how? In: Nance SJ, ed. Transfusion Medicine in the 1990s. Arlington, Va: American Association of Blood Banks; 1990;35-61.
3. Eemisse JG, Brand A. Prevention of platelet refractoriness to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol. 1981;9:77-83.
4. de Graan-Hentzen YCE. Gratama JW, Mudde GC, Verdonck LF, Houbiers JGA, Brand A, Sebens FW, van Loon AM, The TH, Willemse R, de Gast GC. Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion. 1989;29:757-760.
5. Vogelsang GB. Transfusion associated graft-versus-host disease in nonimmunocompromised hosts. Transfusion. 1990;30:101-103.
6. Hisatomi K, Isomura T, Kawara T, Yamashita M, Hirano A, Yoshida H, Eriguchi N, Kosuga K, Ohishi K. Changes in lymphocyte subsets, mitogen responsiveness. and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg. 1989;98:580-591.
7. Jensen LS, Andersen AJ, Christiansen PM, Hokland P. Juhl CO, Madsen G, Mortensen J, Møller-Nielsen C, Hanberg-Sorensen, Hokland M. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 1992; 79:513-516.
8. Tadros T, Wobbes T, Hendriks T. Opposite effects of interleukin-2 on normal and transfusion-suppressed healing of experimental intestinal anastomoses. Ann Surg. 1993;218:800-808.
9. Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes TH, de Vries JE, Klementschitsch P, van de Maas AHM, van de Velde CJH. Randomised controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 1994; 344:573-578.
10. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet. 1996;348:841-845.
11. Diepenhorst P, Sprokholt R, Prins HK. Removal of leukocytes from whole blood and erythrocyte suspensions by filtration through cotton wool, I: filtration techniques. Vox Sang. 1972;23:308-320.
12. Engelfriet CP, Diepenhorst P, Gissen MVD, von Riesz E. Removal of leucocytes from whole blood and erythrocyte suspensions by filtration through cotton wool, IV: immunization studies in rabbits. Vox Sang. 1975;28:81-89.
13. Garcez R, Chong C, Leng B, Carmen R. Degeneration of leukocytes in stored red blood cells. Proceedings of the ISBT/AABB Joint Congress. November 10-15, 1990. Los Angeles, Calif. Abstract S-24.
14. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumours by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood. 1994;84:1;344-348.
15. Williamson LM, Wimperis JZ, Williamson P, Copplestone JA, Gooi HC, Morgenstern GR, and Norfolk DR, for the Alloimmunisation Study Group. Bedside filtration of blood products in the prevention of HLA alloimmunization: a prospective randomized study. Blood. 1994;83:10;3028-3035.
16. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;116: 128-140.
17. Hoogendoorn D. Frequency and surgical mortality in surgery of the heart and of the intrathoracic large vessels, I: direct coronary revascularizations. Ned Tijdschr Geneesk. 1989;133:2445-2448.
18. Hoogendoorn D. Frequency and surgical mortality in surgery of the heart and intrathoracic large vessels. II: operations other than direct coronary revascularization. Ned Tijdschr Geneesk. 1989;133:2448-2452.
19. He GW, Acuff TE, Ryan WH, Bowman RT, Douthit MB, Mack MJ. Determinants of operative mortality in elderly patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:73-81.
20. Lytle BW, Cosgrove DM, Loop FD, Taylor PC, Gill CC, Golding LAR, Goormastic M, Groves LK. Replacement of aortic valve combined with myocardial revascularization: determinants of early and late risk for 500 patients, 1967-1981. Circulaton. 1983;6:1149-1162.
21. Murphy PJ, Connery C, Hicks GL Jr. Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg. 1992;104:1092-1099.
22. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang. 1994;66:14-17.
23. Heddle N.M, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG. A prospective study to identify risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion. 1993;33:794-797.
24. Brecher ME, Pineda AA, Torloni AS, Harbaugh CA, Emery RL. Breanndan Moore S, Carmen R, Nelson E. Prestorage leukocyte depletion: effect on leukocyte and platelet metabolites, erythrocyte lysis, metabolism, and in vivo survival. Semin Hematol. 1991:28(suppl 5):3-9.
25. Nielsen HJ, Reimert CM, Pedersen AN, Brünner N, Edvardsen L, Dybkjær E, Kehlet H, Skov PS. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion. 1996;36:960-965.
26. Malouf M, Glanville AR. Blood transfusion related adult respiratory distress syndrome. Anaesth Intensive Care. 1993;21:44-49.
27. Ramos RR, Curtis BR, Duffy BF, Chaplin H. Low retention of white cell fragments by polyester fiber white cell-reduction platelet filters. Transfusion. 1994;34:31-34.
28. Bareford D, Chandler ST, Hawker RJ, Jackson N, Smith M, Boughton BJ. Splenic platelet-sequestration following routine blood transfusion is reduced by filtered/washed blood products, Br J Haematol. 1987;67:177-180.
29. Waymack JP, Warden GD, Alexander JW, Miskell P, Gonce S. Effect of blood transfusion and anesthesia on resistance to bacterial peritonitis. J Surg Res. 1987;42:528-535.
30. Maetani S, Nishikawa T, Hirakawa A, Tobe T. Role of blood transfusion in organ system failure following major abdominal surgery. Ann Surg. 1986;203:275-281.
31. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lillehei RC, Craddock PR, Jacob HS. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81:370-377.
32. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-559.
33. Lee TH, Donegan E, Slichter S, Busch MP. Transient increase in circulating leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood. 1995;85:1207-1214.
34. Nusbacher J. Blood transfusion is mononuclear cell transplantation. Transfusion. 1994;34:1002-1006.
35. DePalma L, Yu M, McIntosh CL, Swain JA, Davey RJ. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass: the effect of blood transfusion. J Thorac Cardiovasc Surg. 1991;101:240-244.
36. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonaryinduced multisystem organ failure. Ann Thorac Surg. 1993;56:S92-S96.
37. Kubes P. Polymorphonuclear leukocyte-endothelium interactions: a role for pro-inflammatory and anti-inflammatory molecules. Can J Physiol Pharmacol. 1993;71:88-97.
38. Tran DD, Cuesta MA, van Leeuwen PAM, Nauta JJP, Wesdorp RIC. Risk factors for multiple organ system failure and mortality in critically injured patients. Surgery. 1993;114:21-30.